Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimdazenil conversion in insomnia patients dissatisfied with non-benzodiazepine hypnotics
ChiCTR2400089017Phase 4Not yet recruiting
- Sponsor
- Shanghai Mental Health Center
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dimdazenil in Insomnia, sponsored by Shanghai Mental Health Center. Primary endpoint: Proportion of patients satisfied with overall drug treatment after 14 days of Dimdazenil. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2400089017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089017.